Pancreatic Cancer Market: Growth, Trends, and Key Insights 2025 | Top key players - Myriad Genetics Inc., Pfizer Inc., Novartis AG.

The Global Pancreatic Cancer Market reached US$ 2.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.7 billion by 2030. The global Pancreatic Cancer market is expected to exhibit a CAGR of 11.1% during the forecast period (2024-2031).

Pancreatic Cancer Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

The Pancreatic Cancer Market refers to the global landscape focused on diagnosing, treating, and managing pancreatic cancer. With a high mortality rate and limited treatment options, the market is driven by the development of innovative therapies, diagnostic tools, and early detection methods. Advances in personalized medicine, immunotherapy, and targeted therapies are shaping the market's growth and improving patient outcomes.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/pancreatic-cancer-market?sz

Market Opportunities and Growth Drivers:

Increasing Prevalence of Pancreatic Cancer is Driving the Global Pancreatic Cancer Market Growth

Pancreatic cancer is on the rise globally, and understanding the patterns behind its increasing incidence is crucial for developing effective policies and interventions. Countries with higher Human Development Indices (HDI) tend to see higher rates of pancreatic cancer, both in terms of incidence, prevalence, and mortality. In fact, pancreatic cancer is the fourth leading cause of cancer deaths and ranks as the tenth most common cancer in men and the eighth most common in women.

Several factors contribute to the growing incidence of pancreatic cancer, including obesity, passive smoking, and chronic inflammation. Additionally, lifestyle choices such as diet and alcohol consumption influence up to 30% to 50% of the risk. With increasing life expectancy and a rising HDI, the incidence of pancreatic cancer is also climbing in the Asia-Pacific region. However, in some underdeveloped countries in this region, pancreatic cancer is underreported, partly due to inadequate cancer registries.

Pancreatic Cancer Market Recent Development:

Erasca and Pfizer Expand Collaboration to Test ERAS-007 with Ibrance in Cancer Treatment

In October 2022, Erasca announced the expansion of its collaboration with Pfizer to further evaluate ERAS-007 in combination with Pfizer's Ibrance (palbociclib). As part of this extended clinical trial collaboration and supply agreement, both biopharma companies will begin clinical proof-of-concept research. The focus will be on testing this drug combination in patients with colorectal cancer harboring mutations in the NRAS and KRAS genes, as well as those with pancreatic ductal adenocarcinoma who have mutations in the KRAS gene.

List of the Key Players in the Pancreatic Cancer Market:

Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Amgen Inc., Viatris Inc., Boston Scientific Corporation, Clovis Oncology, and GlaxoSmithKline among others.

Research Process:

Both primary and secondary data sources have been used in the global Pancreatic Cancer Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/pancreatic-cancer-market

Segment Covered in the Pancreatic Cancer Market:

By Treatment Type: Targeted Therapies, Chemotherapy, Surgery, Other Treatments.

By End-user: Hospitals, Specialty Clinics, Home care, Others.

Regional Analysis for Pancreatic Cancer Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Pancreatic Cancer Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Pancreatic Cancer market?

➠ Who are the top manufacturers in the global Pancreatic Cancer industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Pancreatic Cancer market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Pancreatic Cancer market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Pancreatic Cancer industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/pancreatic-cancer-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.